SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-120541
Filing Date
2020-11-02
Accepted
2020-11-02 16:28:32
Documents
8
Period of Report
2020-12-01
Effectiveness Date
2020-11-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A a20-34572_1def14a.htm DEF 14A 1149412
2 GRAPHIC g345721bmi001.jpg GRAPHIC 7746
3 GRAPHIC g345721bui001.gif GRAPHIC 294734
4 GRAPHIC g345721bui002.gif GRAPHIC 271214
5 GRAPHIC g345721boi001.jpg GRAPHIC 3016
6 GRAPHIC g345721boi002.jpg GRAPHIC 3489
7 GRAPHIC g345721boi003.jpg GRAPHIC 3735
8 GRAPHIC g345721boi004.jpg GRAPHIC 16834
  Complete submission text file 0001104659-20-120541.txt   1978687
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36294 | Film No.: 201280793
SIC: 2834 Pharmaceutical Preparations